RT @DCiardiello: CAVE-2 is ready to go 📢📢📢 @grikamartinelli @Giulia_Martini1 @napolitano_ste @MassimoDiMaio75 https://t.co/Iter3bQFZr
6,532 followers
349 followers
CAVE-2 is ready to go 📢📢📢 @grikamartinelli @Giulia_Martini1 @napolitano_ste @MassimoDiMaio75 https://t.co/Iter3bQFZr
906 followers
New article: CAVE-2 (Cetuximab-AVElumab) mCRC: A Phase II Randomized Clinical Study of the Combination of Avelumab Plus Cetuximab as a Rechallenge Strategy in Pre-Treated RAS/BRAF Wild-Type mCRC Patients https://t.co/dyvGUqR6zp #colorectalcancer #oncology
6,532 followers
New research: CAVE-2 (Cetuximab-AVElumab) mCRC: A Phase II Randomized Clinical Study of the Combination of Avelumab Plus Cetuximab as a Rechallenge Strategy in Pre-Treated RAS/BRAF Wild-Type mCRC Patients: Introduction Immunotherapy has… https://t.co/ax36